Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients
This randomized, pilot study compared the Janus kinase inhibitor CP-690,550 (15 mg BID [CP15] and 30 mg BID [CP30], n = 20 each) with tacrolimus (n = 21) in de novo kidney allograft recipients. Patients received an IL-2 receptor antagonist, concomitant mycophenolate mofetil (MMF) and corticosteroids...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | 英语 |
出版: |
2009
|
在線閱讀: | https://doi.org/10.1111/j.1600-6143.2009.02720.x http://www.amjtransplant.org/article/S1600613522271184/pdf |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|